Maravai LifeSciences Holdings, Inc. revenue breakdown overview

Maravai LifeSciences Holdings, Inc. revenue for the last year amounted to 259.19 M USD, the most of which — 196.34 M USD — came from its highest performing source at the moment, Nucleic Acid Production, the year earlier bringing 224.77 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Maravai LifeSciences Holdings, Inc. 127.00 M USD, and the year before that — 141.01 M USD.